Back | Next |
home / stock / clsn / clsn message board
Subject | By | Source | When |
---|---|---|---|
$CLSN...$2.22...Taking a starter here...Looking for a Double Top | georgie18 | investorshub | 03/15/2021 11:01:35 AM |
Look @ the options. Big bet this is | traderbbc1 | investorshub | 03/04/2021 5:25:46 PM |
I made a quick flip this AM pre... | DavesDisposable | investorshub | 02/25/2021 9:02:54 PM |
not today cant break 2.50s in pre shortie in control | peterus | investorshub | 02/25/2021 2:22:47 PM |
$10.00 on the way... | DavesDisposable | investorshub | 02/25/2021 1:54:43 PM |
The new$ GEN-1 technology is groundbreaking. | ThousandDollarSuit | investorshub | 02/23/2021 10:31:22 AM |
* * $CLSN Video Chart 02-22-2021 * * | ClayTrader | investorshub | 02/22/2021 9:19:03 PM |
Lets hope you are right | Rfulwi6231 | investorshub | 02/22/2021 8:11:33 PM |
$5 PLUS ON ITS WAY | OH NO- NOT AGAIN | investorshub | 02/22/2021 6:56:25 PM |
February 22, 2021 08:57 AM ET | ThousandDollarSuit | investorshub | 02/22/2021 3:29:44 PM |
$CLSN is screaming for the top after the | AlphaStockNews | investorshub | 02/22/2021 1:20:20 PM |
* * $CLSN Video Chart 02-11-2021 * * | ClayTrader | investorshub | 02/11/2021 10:34:39 PM |
look out. big shorts here too. Oh BOY | traderbbc1 | investorshub | 02/11/2021 2:55:20 PM |
I just took a hard look at the | traderbbc1 | investorshub | 02/11/2021 1:29:42 PM |
Just profit takers from Monday's .50 up day , | scooter1ar | investorshub | 02/10/2021 11:27:12 PM |
Correction? Risk/Reward play here. | traderbbc1 | investorshub | 02/10/2021 3:50:12 PM |
could be a squeeze from the shorts that | rivervalley | investorshub | 02/05/2021 2:50:11 PM |
I think a slow but steady climb is | scooter1ar | investorshub | 02/04/2021 11:43:06 PM |
waiting on this one to go. Seems like | rivervalley | investorshub | 02/04/2021 10:53:52 PM |
wait till Monday big news coming, buy now | trity | investorshub | 01/30/2021 7:13:22 PM |
News, Short Squeeze, Breakout and More Instantly...
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage drug development company, today announced ...
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone LAWRENCEVILLE, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage company focused on DNA-ba...
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24 th An...